Efficacy and Safety of Therapy With IgM-enriched Immunoglobulin With a Personalized Dose vs Standard Dose in Patients With Septic Shock.
Clinical trial NCT04182737 · UNKNOWN
Trial details
- NCT number
- NCT04182737
- Sponsor
- Massimo Girardis
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2022-02-28
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.